{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T18:31:10Z","timestamp":1774117870771,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.atherosclerosis.2015.06.047","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T10:00:33Z","timestamp":1435744833000},"page":"19-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of HbA1c as a prognostic biomarker of cardiovascular events and mortality in nondiabetic patients: Methodological considerations"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6491-0607","authenticated-orcid":false,"given":"Denis","family":"Monneret","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.06.047_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.atherosclerosis.2015.02.053","article-title":"Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: a prospective cohort study","volume":"240","author":"Rebnord","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.06.047_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ab.2004.10.002","article-title":"A quantitative method for the analysis of glycated and glutathionylated hemoglobin by matrix-assisted laser desorption ionization-time of flight mass spectrometry","volume":"336","author":"Biroccio","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.atherosclerosis.2015.06.047_bib3","unstructured":"National Glycohemoglobin Standardization Program (NGSP), http:\/\/www.ngsp.org\/docs\/methods.pdf, (2015, accessed 21.04.15)."},{"key":"10.1016\/j.atherosclerosis.2015.06.047_bib4","unstructured":"International Federation of Clinical Chemistry (IFCC) Task Force on Implementation of HbA1c Standardization, http:\/\/www.ifcc.org\/executive-board-and-council\/eb-task-forces\/task-force-hba1c\/, (2015, accessed 21.04.15)."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2015.06.047_bib5","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2337\/dc07-9925","volume":"30","author":"Consensus Committee","year":"2007","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.06.047_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1373\/clinchem.2010.148841","article-title":"National glycohemoglobin standardization program (NGSP) steering Committee, status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care","volume":"57","author":"Little","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.06.047_bib7","unstructured":"National Glycohemoglobin Standardization Program (NGSP), http:\/\/www.ngsp.org\/cert\/Level1info0314.pdf, (2015, accessed 21.04.15)."},{"key":"10.1016\/j.atherosclerosis.2015.06.047_bib8","unstructured":"National Glycohemoglobin Standardization Program (NGSP), http:\/\/www.ngsp.org\/protln.asp, (2015, accessed 21.04.15)."},{"key":"10.1016\/j.atherosclerosis.2015.06.047_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2012.12.026","article-title":"The long and winding road to optimal HbA1c measurement","volume":"418","author":"Little","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2015.06.047_bib10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1515\/CCLM.2007.158","volume":"45","author":"Goodall","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.atherosclerosis.2015.06.047_bib11","unstructured":"Westgard website, Desirable Biological Variation Database specifications, http:\/\/www.westgard.com\/biodatabase1.htm, (2015, accessed 21.04.15)."},{"key":"10.1016\/j.atherosclerosis.2015.06.047_bib12","unstructured":"National Committee for Clinical Laboratory Standards, Evaluation Of precision performance of quantitative measurement methods; Approved Guideline; Second ed., NCCLS document EP5\u2013A2 (ISBN 1-56238-542-9)."},{"key":"10.1016\/j.atherosclerosis.2015.06.047_bib13","unstructured":"National Committee for Clinical Laboratory Standards, Method comparison and bias estimation using patient samples; Approved Guideline; Second ed., NCCLS document EP9\u2013A2 (ISBN 1-56238-472-4)."},{"issue":"Suppl. 1","key":"10.1016\/j.atherosclerosis.2015.06.047_bib14","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","article-title":"Diagnosis and classification of diabetes mellitus","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"issue":"21\u201322","key":"10.1016\/j.atherosclerosis.2015.06.047_bib15","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.cca.2010.07.030","article-title":"Biological variability of glycated haemoglobin","volume":"411","author":"Braga","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"15\u201316","key":"10.1016\/j.atherosclerosis.2015.06.047_bib16","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cca.2011.04.014","article-title":"Revaluation of biological variation of glycated hemoglobin (HbA(1c)) using an accurately designed protocol and an assay traceable to the IFCC reference system","volume":"412","author":"Braga","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2015.06.047_bib17","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1515\/cclm-2013-0060","article-title":"Standardization and analytical goals for glycated hemoglobin measurement","volume":"51","author":"Braga","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2015.06.047_bib18","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2337\/dc13-2357","article-title":"Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA(1c) according to American diabetes association criteria","volume":"37","author":"Di Pino","year":"2014","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.06.047_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2337\/diacare.26.1.144","article-title":"The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study","volume":"26","author":"Gerstein","year":"2003","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2015.06.047_bib20","doi-asserted-by":"crossref","first-page":"E1461","DOI":"10.1210\/jc.2010-2697","article-title":"Glycated hemoglobin A1c, fasting plasma glucose, and two-hour postchallenge plasma glucose levels in relation to carotid intima-media thickness in chinese with normal glucose tolerance","volume":"96","author":"Huang","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.06.047_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/dc09-1009","article-title":"A1C is associated with intima-media thickness in individuals with normal glucose tolerance","volume":"33","author":"Bobbert","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.06.047_bib22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4093\/dmj.2014.38.1.58","article-title":"Assessment of the association between mean hemoglobin A1c levels for 5 Years and coronary artery disease by coronary angiography in nondiabetic patients","volume":"38","author":"Kim","year":"2014","journal-title":"Diabetes Metab. J."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2015.06.047_bib23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/01.CIR.0000136809.55141.3B","article-title":"Glycated hemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals: the Troms\u00f8 study","volume":"110","author":"J\u00f8rgensen","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.06.047_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2337\/dc14-0360","article-title":"Hemoglobin a1c and the progression of coronary artery calcification among adults without diabetes","volume":"38","author":"Carson","year":"2015","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2015.06.047_bib25","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2337\/dc10-2010","article-title":"Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography","volume":"34","author":"Silbernagel","year":"2011","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2015.06.047_bib26","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0908359","article-title":"Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults","volume":"362","author":"Selvin","year":"2010","journal-title":"N. Engl. J. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015300058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015300058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T02:58:46Z","timestamp":1537498726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015300058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0021915015300058"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.06.047","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of HbA1c as a prognostic biomarker of cardiovascular events and mortality in nondiabetic patients: Methodological considerations","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}